Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
3.550
+0.030 (0.85%)
Apr 6, 2026, 4:00 PM EDT - Market closed
Sight Sciences Revenue
In the year 2025, Sight Sciences had annual revenue of $77.36M, down -3.13%. Sight Sciences had revenue of $20.39M in the quarter ending December 31, 2025, with 6.87% growth.
Revenue (ttm)
$77.36M
Revenue Growth
-3.13%
P/S Ratio
2.48
Revenue / Employee
$415,930
Employees
186
Market Cap
191.72M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.36M | -2.50M | -3.13% |
| Dec 31, 2024 | 79.87M | -1.19M | -1.47% |
| Dec 31, 2023 | 81.06M | 9.73M | 13.63% |
| Dec 31, 2022 | 71.33M | 22.38M | 45.70% |
| Dec 31, 2021 | 48.96M | 21.32M | 77.12% |
| Dec 31, 2020 | 27.64M | 4.29M | 18.38% |
| Dec 31, 2019 | 23.35M | 15.82M | 210.07% |
| Dec 31, 2018 | 7.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 348.67M |
| InfuSystem Holdings | 143.44M |
| Quanterix | 138.90M |
| Electromed | 68.86M |
| CVRx, Inc. | 56.65M |
| 908 Devices | 56.20M |
| Apyx Medical | 52.84M |
| Profound Medical | 16.10M |
SGHT News
- 5 days ago - Sight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting - GlobeNewsWire
- 7 days ago - Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th - GlobeNewsWire
- 7 days ago - Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury's Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent - GlobeNewsWire
- 4 weeks ago - Sight Sciences Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 4 weeks ago - Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance - GlobeNewsWire
- 6 weeks ago - Sight Sciences to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 - GlobeNewsWire
- 2 months ago - Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Highlights - GlobeNewsWire
- 5 months ago - Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance - GlobeNewsWire